| Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with … M Dowsett, J Cuzick, C Wale, J Forbes, EA Mallon, J Salter, E Quinn, ... Journal of Clinical Oncology 28 (11), 1829-1834, 2010 | 844 | 2010 |
| Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy M Dowsett, I Sestak, E Lopez-Knowles, K Sidhu, AK Dunbier, JW Cowens, ... Journal of Clinical Oncology 31 (22), 2783-2790, 2013 | 742 | 2013 |
| Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer WM Grady, J Willis, PJ Guilford, AK Dunbier, TT Toro, H Lynch, G Wiesner, ... Nature genetics 26 (1), 16-17, 2000 | 555 | 2000 |
| Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene … DC Sgroi, I Sestak, J Cuzick, Y Zhang, CA Schnabel, B Schroeder, ... The lancet oncology 14 (11), 1067-1076, 2013 | 438 | 2013 |
| ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer TW Miller, JM Balko, EM Fox, Z Ghazoui, A Dunbier, H Anderson, ... Cancer discovery 1 (4), 338-351, 2011 | 361 | 2011 |
| Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer M Dowsett, AK Dunbier Clinical Cancer Research 14 (24), 8019-8026, 2008 | 318 | 2008 |
| Molecular profiling of aromatase inhibitor–treated postmenopausal breast tumors identifies immune-related correlates of resistance AK Dunbier, Z Ghazoui, H Anderson, J Salter, A Nerurkar, P Osin, ... Clinical Cancer Research 19 (10), 2775-2786, 2013 | 159 | 2013 |
| Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer B Humar, R Fukuzawa, V Blair, A Dunbier, H More, A Charlton, HK Yang, ... Cancer research 67 (6), 2480-2489, 2007 | 150 | 2007 |
| Accurate prediction and validation of response to endocrine therapy in breast cancer AK Turnbull, LM Arthur, L Renshaw, AA Larionov, C Kay, AK Dunbier, ... Journal of Clinical Oncology 33 (20), 2270-2278, 2015 | 127 | 2015 |
| Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor–positive breast cancer in postmenopausal women AK Dunbier, H Anderson, Z Ghazoui, EJ Folkerd, R A'hern, RJ Crowder, ... Journal of clinical oncology 28 (7), 1161-1167, 2010 | 124 | 2010 |
| A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance TW Miller, JM Balko, Z Ghazoui, A Dunbier, H Anderson, M Dowsett, ... Clinical Cancer Research 17 (7), 2024-2034, 2011 | 118 | 2011 |
| Endocrine therapy, new biologicals, and new study designs for presurgical studies in breast cancer M Dowsett, I Smith, J Robertson, L Robison, I Pinhel, L Johnson, J Salter, ... Journal of the National Cancer Institute Monographs 2011 (43), 120-123, 2011 | 97 | 2011 |
| Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers A Aiderus, MA Black, AK Dunbier Bmc Cancer 18, 1-15, 2018 | 75 | 2018 |
| ESR1 Is Co-Expressed with Closely Adjacent Uncharacterised Genes Spanning a Breast Cancer Susceptibility Locus at 6q25.1 AK Dunbier, H Anderson, Z Ghazoui, E Lopez-Knowles, S Pancholi, ... PLoS genetics 7 (4), e1001382, 2011 | 72 | 2011 |
| Exploring breast cancer estrogen disposition: the basis for endocrine manipulation PE Lønning, BP Haynes, AH Straume, A Dunbier, H Helle, S Knappskog, ... Clinical cancer research 17 (15), 4948-4958, 2011 | 66 | 2011 |
| Association between breast cancer subtypes and response to neoadjuvant anastrozole AK Dunbier, H Anderson, Z Ghazoui, J Salter, JS Parker, CM Perou, ... Steroids 76 (8), 736-740, 2011 | 63 | 2011 |
| Hereditary diffuse gastric cancer A Dunbier, P Guilford Academic Press 83, 55-65, 2001 | 63 | 2001 |
| Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1 SA Jamieson, Z Ruan, AE Burgess, JR Curry, HD McMillan, JL Brewster, ... Science signaling 11 (549), eaau0597, 2018 | 61 | 2018 |
| Effect of aromatase inhibition on functional gene modules in estrogen receptor–positive breast cancer and their relationship with antiproliferative response Q Gao, N Patani, AK Dunbier, Z Ghazoui, M Zvelebil, LA Martin, ... Clinical cancer research 20 (9), 2485-2494, 2014 | 54 | 2014 |
| ERalphadependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer. Cancer Discov. 2011; 1: 338-51. doi: 10.1158/2159-8290 TW Miller, JM Balko, EM Fox, Z Ghazoui, A Dunbier, H Anderson, ... CD-11-0101, 0 | 53 | |
